WeVote
Log In

Bill

Bill

SB 209

Revises provisions relating to pharmacy benefit managers. (BDR 57-534)

2025 Regular Session Introduced by Carrie Buck and 6 co-sponsors

Nevada bill revises pharmacy benefit manager regulations to address drug pricing, network access, and transparency in prescription drug administration.

(Pursuant to Joint Standing Rule No. 14.3.1, no further action allowed.)
0
WeVote Research Nonpartisan
Bill Summary · SB 209

Legislative bill overview

SB 209 revises Nevada's regulatory framework governing pharmacy benefit managers (PBMs), which are intermediaries that manage prescription drug benefits for insurance plans and employers. The bill's specific provisions are not detailed in the available legislative history, but it addresses how PBMs operate within the state's healthcare system.

Why is this important

PBMs significantly influence drug pricing, pharmacy access, and healthcare costs for Nevada consumers and employers. Regulatory changes to PBM practices can affect prescription affordability, which pharmacy networks patients can use, and transparency in how drug costs are determined—issues that impact both individual patients and the state's healthcare landscape.

Potential points of contention

  • PBM transparency vs. competitive concerns – Requiring disclosure of PBM pricing methods and formulary decisions could increase consumer understanding but may face industry opposition claiming proprietary information protection
  • Pharmacy network access – Restrictions on which pharmacies PBMs can exclude from networks may benefit rural access but could increase administrative costs
  • Drug pricing mechanisms – Any provisions affecting rebate structures, spread pricing (where PBMs pocket the difference between reimbursement rates), or generic drug incentives will likely pit patient advocates against industry stakeholders

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.